New combo aims to shield heart while fighting tumors
Disease control
Recruiting now
This early-phase study tests a new drug called RC220 given with the chemotherapy doxorubicin in adults with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to find a safe dose and see if RC220 can protect the heart from doxorubicin's sid…
Phase: PHASE1 • Sponsor: Racura Oncology Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC